Tulstrup M, et al. - Authors in this randomized controlled trial tested the hypothesis that children with non-high risk acute lymphoblastic leukemia could benefit from individualized 6-mercaptopurine increments during consolidation therapy (NCT00816049). Findings revealed no benefit from individualized 6-mercaptopurine increments compared to standard therapy.